In the first session, IHI Executive Director Dr Pierre Meulien will present IHI and explain why a new European partnership for health is launched. He will also describe what's new compared to the Innovative Medicines Initiative (IMI), and what will stay the same. IHI staff will then present opportunities for stakeholders to get involved in IHI, for example by applying to become a member of the IHI Science and Innovation Panel (SIP), or by becoming an expert evaluator. They will also offer a preview of the draft topics under consideration for inclusion in the first IHI call for proposals.
The second session will feature a high-level discussion during which representatives of the IHI partners, namely the European Commission, the European Parliament, COCIR, EFPIA , Vaccines Europe, EuropaBio and MedTech Europe, will present their vision for IHI.
Both sessions will include time for questions from participants.
The Innovative Health Initiative Joint Undertaking (IHI JU) is looking for members of its scientific advisory body, the Science and Innovation Panel.
Candidates are sought in two categories:
- Representatives of the scientific community, including technology research,
- Representatives of stakeholders involved in health care, such as patients, health care professionals, health care providers, regulatory bodies, health technology assessment bodies and health care payers.
The call for expression of interest to select members is now open until 21 February 2022. Further information on application procedure can be found here: https://www.ihi.europa.eu/news-events/newsroom/innovative-health-initiative-seeks-scientific-and-health-experts-join-advisory